Overview of Dr. Amengual
Dr. Jennifer Amengual is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from New York Medical College and has been in practice 13 years. She is one of 368 doctors at New York-Presbyterian Hospital and one of 115 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She has more than 40 publications and over 500 citings.
Office
161 Fort Washington Avenue
New York, NY 10032- Is this information wrong?
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2004 - 2007
New York Medical CollegeClass of 2004
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2007 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) Start of enrollment: 2012 Oct 31
- Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies Start of enrollment: 2013 Sep 09
- ACY-1215 for Relapsed/Refractory Lymphoid Malignancies Start of enrollment: 2014 Apr 02
- Join now to see all
Publications & Presentations
PubMed
- Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-...Brian Estrella, Mark M Francescone, Yun Kyoung Ryu Tiger, Salvia Jain, Stefan K Barta, Seda Tolu, Ahmed Sawas, Jennifer K Lue, Barbara Pro, Jennifer E Amengual> ;Leukemia & Lymphoma. 2024 Mar 22
- Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.Gerson, J., Handorf, E., Villa, D., Gerrie, A., Chapani, P., Li, S., Medeiros, L., Wang, M., Cohen, J., Churnetski, M., Hill, B., Sawalha, Y., Hernandez-Ilizaliturri, ...> ;Blood Advances. 2023 Dec 26
- 1 citationsHow I treat posttransplant lymphoproliferative disorder.Jennifer E Amengual, Barbara Pro> ;Blood. 2023 Oct 26
- Join now to see all
Abstracts/Posters
- Strategy for Overcoming Crebbp and EP300 Mutations in Lymphoma: Development of First-in-Class HAT ActivatorsJennifer E Amengual, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 StudiesJennifer E. Amengual, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Hospital Affiliations
New York-Presbyterian HospitalNew York, New York
NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
